Finerenone and Cardiac Remodeling
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 156 participants.
Also called NCT07270367
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 156 participants
- Sponsor
- Registry
-
NCT07270367
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07270367. Randomized; quadruple masking; primary purpose treatment. Start 2025-12 (anticipated); primary completion 2030-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Finerenone and Cardiac Remodeling
- Acronym
- FINE-MECH
- Condition
- Heart Failure
- Intervention (Drug)
- Finerenone
- Intervention (Drug)
- Placebo
- Lead sponsor
- Subodh Verma
- Collaborator
- Bayer
Record details
- Record id
cardio:ct-nct07270367- Content hash
ef21b8c9e3f36b46da1ca2be5200d07073e4b5f0a2c2128e60a1d3565adce9e6